You are viewing an old version of this page. View the current version .
Compare with Current
View Page History
« Previous
Version 17
Next »
This an example of a cross-over study where 7 smokeless tobacco products were tested. All product contain nicotine except for product F, which was a nicotine/tobacco free product. Subject used the product ad libitum and then the next day the product was evaluated as specified in the protocol in the morning. The subjects were confined to the site. Product were supplied to the subject as needed by site staff. Each usage was recorded. The sponsor did not submit a Product Accountability (DA) domain, or the EC domain. The name of the actual product would be used but was not used in the example below.
ex.xpt
ex.xpt
ex.xpt
Row STUDYID DOMAIN USUBJID EXSEQ EXTRT EXCAT EXDOSE EXDOSU EXDOSFRM EXROUTE EXPSTRG EXPSTRGU VISITNUM VISIT VISITDY EPOCH EXSTDTC EXENDTC 1 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 1 PRODUCT C UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 6 mg 10 DAY -1 -1 TREATMENT 2019-06-27T13:10:33 2019-06-27T13:38:49 2 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 2 PRODUCT C UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 6 mg 10 DAY -1 -1 TREATMENT 2019-06-27T14:29:13 2019-06-27T14:54:53 3 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 3 PRODUCT C CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 6 mg 11 DAY 1 1 TREATMENT 2019-06-28T08:00:12 2019-06-28T08:30:21 4 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 4 PRODUCT E UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 4 mg 11 DAY 1 1 TREATMENT 2019-06-28T14:01:52 2019-06-28T14:55:27 5 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 5 PRODUCT E UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 4 mg 11 DAY 1 1 TREATMENT 2019-06-28T15:18:35 2019-06-28T15:57:33 6 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 6 PRODUCT E CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 4 mg 12 DAY 2 2 TREATMENT 2019-06-29T08:00:08 2019-06-29T08:30:13 7 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 7 PRODUCT B UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 2 mg 12 DAY 2 2 TREATMENT 2019-06-29T14:01:50 2019-06-29T14:50:11 8 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 8 PRODUCT B UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 2 mg 12 DAY 2 2 TREATMENT 2019-06-29T15:24:33 2019-06-29T15:59:46 9 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 9 PRODUCT B CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 2 mg 13 DAY 3 3 TREATMENT 2019-06-30T08:00:00 2019-06-30T08:30:00 10 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 10 PRODUCT D UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 6 mg 13 DAY 3 3 TREATMENT 2019-06-30T14:12:32 2019-06-30T14:47:47 11 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 11 PRODUCT D UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 6 mg 13 DAY 3 3 TREATMENT 2019-06-30T15:24:46 2019-06-30T16:04:57 12 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 12 PRODUCT D CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 6 mg 14 DAY 4 4 TREATMENT 2019-07-01T08:00:00 2019-07-01T08:30:00 13 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 13 PRODUCT A UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 8 mg 14 DAY 4 4 TREATMENT 2019-07-01T14:02:36 2019-07-01T14:47:33 14 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 14 PRODUCT A UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 8 mg 14 DAY 4 4 TREATMENT 2019-07-01T15:37:45 2019-07-01T15:58:15 15 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 15 PRODUCT A CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 8 mg 15 DAY 5 5 TREATMENT 2019-07-02T08:00:00 2019-07-02T08:30:01 16 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 16 PRODUCT F UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 0 mg 15 DAY 5 5 TREATMENT 2019-07-02T14:11:00 2019-07-02T14:54:08 17 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 17 PRODUCT F UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 0 mg 15 DAY 5 5 TREATMENT 2019-07-02T15:38:52 2019-07-02T15:59:50 18 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 18 PRODUCT F CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 0 mg 16 DAY 6 6 TREATMENT 2019-07-03T08:00:00 2019-07-03T08:30:00 19 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 19 PRODUCT G UNCONTROLLED PRODUCT USE 3.37 g QUID ORAL 4 mg 16 DAY 6 6 TREATMENT 2019-07-03T14:13:14 2019-07-03T14:57:40 20 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 20 PRODUCT G UNCONTROLLED PRODUCT USE 3.2 g QUID ORAL 4 mg 16 DAY 6 6 TREATMENT 2019-07-03T15:35:01 2019-07-03T16:07:25 21 ALCS-REG-STUDY EX ALCS-REG-STUDY_10001 21 PRODUCT G CONTROLLED PRODUCT USE 2 g QUID ORAL 4 mg 17 DAY 7/EARLY TERMINATION 7 TREATMENT 2019-07-04T08:00:04 2019-07-04T08:30:05 22 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 1 PRODUCT E UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 8 mg 10 DAY -1 -1 TREATMENT 2019-07-04T14:06:09 2019-07-04T14:14:14 23 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 2 PRODUCT E CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 8 mg 11 DAY 1 1 TREATMENT 2019-07-05T08:00:00 2019-07-05T08:30:00 24 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 3 PRODUCT D UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 4 mg 11 DAY 1 1 TREATMENT 2019-07-05T14:02:39 2019-07-05T14:18:57 25 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 4 PRODUCT D CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 4 mg 12 DAY 2 2 TREATMENT 2019-07-06T08:00:00 2019-07-06T08:30:00 26 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 5 PRODUCT C UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 6 mg 12 DAY 2 2 TREATMENT 2019-07-06T14:00:00 2019-07-06T14:08:40 27 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 6 PRODUCT C UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 6 mg 12 DAY 2 2 TREATMENT 2019-07-06T15:52:53 2019-07-06T15:59:21 28 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 7 PRODUCT C CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 6 mg 13 DAY 3 3 TREATMENT 2019-07-07T08:00:00 2019-07-07T08:30:00 29 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 8 PRODUCT F UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 2 mg 13 DAY 3 3 TREATMENT 2019-07-07T14:01:12 2019-07-07T14:12:25 30 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 9 PRODUCT F UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 0 mg 13 DAY 3 3 TREATMENT 2019-07-07T14:57:49 2019-07-07T15:07:07 31 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 10 PRODUCT F CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 0 mg 14 DAY 4 4 TREATMENT 2019-07-08T08:00:00 2019-07-08T08:30:00 32 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 11 PRODUCT B UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 0 mg 14 DAY 4 4 TREATMENT 2019-07-08T14:00:52 2019-07-08T14:17:31 33 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 12 PRODUCT B UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 2 mg 14 DAY 4 4 TREATMENT 2019-07-08T14:46:07 2019-07-08T14:53:43 34 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 13 PRODUCT B CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 2 mg 15 DAY 5 5 TREATMENT 2019-07-09T08:00:01 2019-07-09T08:30:01 35 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 14 PRODUCT G UNCONTROLLED PRODUCT USE 2.69 g QUID ORAL 4 mg 15 DAY 5 5 TREATMENT 2019-07-09T14:06:24 2019-07-09T14:30:16 36 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 15 PRODUCT G UNCONTROLLED PRODUCT USE 3.3 g QUID ORAL 4 mg 15 DAY 5 5 TREATMENT 2019-07-09T14:49:39 2019-07-09T15:15:16 37 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 16 PRODUCT G CONTROLLED PRODUCT USE 2 g QUID ORAL 4 mg 16 DAY 6 6 TREATMENT 2019-07-10T08:00:00 2019-07-10T08:30:00 38 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 17 PRODUCT A UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 8 mg 16 DAY 6 6 TREATMENT 2019-07-10T14:02:07 2019-07-10T14:35:40 39 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 18 PRODUCT A UNCONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 8 mg 16 DAY 6 6 TREATMENT 2019-07-10T15:27:37 2019-07-10T15:58:24 40 ALCS-REG-STUDY EX ALCS-REG-STUDY_10002 19 PRODUCT A CONTROLLED PRODUCT USE 1 POUCH POUCH ORAL 8 mg 17 DAY 7/EARLY TERMINATION 7 TREATMENT 2019-07-11T08:00:00 2019-07-11T08:30:00
$warningHtml